Clinical Updates in Treating Advanced Prostate Cancer - Episode 4

Recent Data on ARPI-Based Combination Regimens

,

Panelists discuss how recent data on androgen receptor pathway inhibitor–based combination regimens highlight their potential to enhance treatment outcomes for advanced prostate cancer, underscoring the importance of integrating these findings into clinical practice.

EP. 1: Treatment Landscape and Sequencing of Therapies
EP. 2: Treatment Timelines Related to Disease State and Use of Monotherapy
EP. 3: Genetic Testing – Germline
Now Viewing
EP. 4: Recent Data on ARPI-Based Combination Regimens
EP. 5: Genetic Testing – Somatic
EP. 6: ARPI-Based Combination Regimens – PEACE-3 (Radium-223 and enzalutamide)

If you have a patient who comes to your clinic and they are coming in for a second opinion to ensure optimized therapy, do you ever offer 6 cycles of docetaxel?

Related Content:

Clinical Updates in Treating Advanced Prostate Cancer
Genetic Testing – Somatic
ARPI-Based Combination Regimens – PEACE-3 (Radium-223 and enzalutamide)
Genetic Testing – Germline